Johannes Gädke, born in Alfeld (Leine), Germany, has studied biotechnology with focus on bioprocess engineering from 2008 until 2013 at the Technische Universität Carolo-Wilhelmina in Braunschweig, Germany. After his studies in Waterloo, Ontario, Canada from 2011 until 2012, aided by a scholoarship from the German Academic Exchange Service, he completed his master thesis in Germany with the degree M. Sc. Biotechnology. He started his PhD-studies in the autumn of 2013 at the Institute of Biochemical Engineering which he finished in early 2017. His research was situated within the scientific research group SynFoBia, Novel synthesis and formulation methods for poorly soluble drugs and sensitive biopharmaceuticals, at the Center of Pharmaceutical Engineering in Braunschweig, Germany.